Dr. C. Ben Schwamb is a patent agent in the New York office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. He assists with the preparation and prosecution of patent applications in the fields of chemistry, pharmaceuticals, and biotechnology.
Prior to joining the firm, Ben conducted doctoral research at Northwestern University under the supervision of Professor Karl A. Scheidt, where he studied the design and application of N-heterocyclic carbene catalysts in the production of medicinally privileged small molecules. As a result of this experience, he has a strong background in the multi-step synthesis of complex organic and organometallic compounds, as well as the application of modern analytical methods for structural, electronic, and mechanistic characterization of molecules and reactions.
Dr. C. Ben Schwamb is a patent agent in the New York office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. He assists with the preparation and prosecution of patent applications in the fields of chemistry, pharmaceuticals, and biotechnology.
Prior to joining the firm, Ben conducted doctoral research at Northwestern University under the supervision of Professor Karl A. Scheidt, where he studied the design and application of N-heterocyclic carbene catalysts in the production of medicinally privileged small molecules. As a result of this experience, he has a strong background in the multi-step synthesis of complex organic and organometallic compounds, as well as the application of modern analytical methods for structural, electronic, and mechanistic characterization of molecules and reactions.
- Ph.D., Synthetic Organic Chemistry, Northwestern University, 2018
- B.A., Chemistry, Grinnell College, 2012With Honors
- U.S. Patent and Trademark Office
- Ph.D., Synthetic Organic Chemistry, Northwestern University, 2018
- B.A., Chemistry, Grinnell College, 2012With Honors
- U.S. Patent and Trademark Office
Select Publications
- Co-author with C. T. Check, K. P. Jang, A. S. Wong, M. H. Wang, and K. A. Scheidt, "Ferrocene-Based Planar Chiral Imidazopyridinium Salts for Catalysis," 54(19) Angewante Chemie International Edition 4264-68, 2015
- Co-author with M. H. Wang, D. T. Cohen, R. K. Mishra, and K. A. Scheidt, "Enantioselective β-Protonation by a Cooperative Catalysis Strategy," 137(18) Journal of the American Chemical Society5891-94, 2015
- Co-author with M. H. Wang, D. N. Barsoum, D. T. Cohen, B. C. Goess, M. Riedrich, A. Chan, B. Maki, R. K. Mishra, and K. A. Scheidt, "Catalytic, Enantioselective β-Protonation Through a Cooperative Activation Strategy," 82(8) The Journal of Organic Chemistry 4689-4702, 2017
- Co-author with K. P. Fitzpatrick, A. C. Brueckner, C. H. Richardson, P. H.-Y. Cheong, and K. A. Scheidt, "Enantioselective Synthesis of α-Aminoboronates Catalyzed by Planar-Chiral NHC-Cu(I) Complexes," 140(34) Journal of the American Chemical Society 10644-48, 2018
Select Publications
- Co-author with C. T. Check, K. P. Jang, A. S. Wong, M. H. Wang, and K. A. Scheidt, "Ferrocene-Based Planar Chiral Imidazopyridinium Salts for Catalysis," 54(19) Angewante Chemie International Edition 4264-68, 2015
- Co-author with M. H. Wang, D. T. Cohen, R. K. Mishra, and K. A. Scheidt, "Enantioselective β-Protonation by a Cooperative Catalysis Strategy," 137(18) Journal of the American Chemical Society5891-94, 2015
- Co-author with M. H. Wang, D. N. Barsoum, D. T. Cohen, B. C. Goess, M. Riedrich, A. Chan, B. Maki, R. K. Mishra, and K. A. Scheidt, "Catalytic, Enantioselective β-Protonation Through a Cooperative Activation Strategy," 82(8) The Journal of Organic Chemistry 4689-4702, 2017
- Co-author with K. P. Fitzpatrick, A. C. Brueckner, C. H. Richardson, P. H.-Y. Cheong, and K. A. Scheidt, "Enantioselective Synthesis of α-Aminoboronates Catalyzed by Planar-Chiral NHC-Cu(I) Complexes," 140(34) Journal of the American Chemical Society 10644-48, 2018
Biological Sciences and Biotechnology
- Biochemistry
- Bioconjugation
- Molecular biology
Therapeutics and Drug Discovery
- Antimicrobial agents
- Drug conjugates
- Drug conjugates based drug discovery
- Drug delivery
- Gene editing
- Neuropharmacology
- Peptide therapeutics
- Pharmacodynamics
- Pharmacokinetics
- Small molecule synthesis
- Small molecules
Diagnostics and Medical Devices
- Diagnostics
Chemistry and Material Science
- Catalysis
- Chemical synthesis
- Chemistry
- Chemoenzymatic synthesis
- Green chemistry
- Materials chemistry
- Organic chemistry
- Organometallics
- Peptidomimetics
- Polymers
- Polymorph
- Process chemistry
Miscellaneous
- Cancer
- Formulations
Biological Sciences and Biotechnology
- Biochemistry
- Bioconjugation
- Molecular biology
Therapeutics and Drug Discovery
- Antimicrobial agents
- Drug conjugates
- Drug conjugates based drug discovery
- Drug delivery
- Gene editing
- Neuropharmacology
- Peptide therapeutics
- Pharmacodynamics
- Pharmacokinetics
- Small molecule synthesis
- Small molecules
Diagnostics and Medical Devices
- Diagnostics
Chemistry and Material Science
- Catalysis
- Chemical synthesis
- Chemistry
- Chemoenzymatic synthesis
- Green chemistry
- Materials chemistry
- Organic chemistry
- Organometallics
- Peptidomimetics
- Polymers
- Polymorph
- Process chemistry
Miscellaneous
- Cancer
- Formulations
- Privacy Policy
- Terms of Use
- Accessibility